ClinicalTrials.Veeva

Menu

Retinal Function in Relation to Long Term Changes in the Glucose Level

G

Glostrup University Hospital, Copenhagen

Status

Unknown

Conditions

Diabetes Mellitus

Treatments

Other: Insulin pump

Study type

Observational

Funder types

Other

Identifiers

NCT00973401
Holfort

Details and patient eligibility

About

The purpose of this study is to measure the amplitude and implicit time of electroretinogram (ERG), darkadaptation and the calibre of retinal vessels before and after optimized medical treatment of diabetic individuals (a lower blood glucose level) over a period of 12 months. Newly diagnosed type 1 and type 2 diabetics as well as dysregulated type 1 and type 2 diabetic individuals will be included. Retinal vessel calibre measurements will be used as an estimation of changes in the retinal perfusion.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Dysregulated type 1 diabetic individuals and newly diagnosed type 1 diabetics. Age >17 < 60 years

Exclusion criteria

  • Test individuals with significant cataract, prior surgery to the eye, diabetic retinopathy, other serious eye disease, hypertension, other serious systemic disease.

Trial design

30 participants in 1 patient group

Diabetic individuals
Treatment:
Other: Insulin pump

Trial contacts and locations

1

Loading...

Central trial contact

Stig Holfort, medical doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems